News|Podcasts|October 25, 2022
Accelerating New Medicines: Innovation and Technology at Curia
Author(s)Curia
Curia is proud to partner with pharma and biotech companies to make new medicines that save lives. In order to be able to do that, Curia needs to be constantly innovating. In this podcast, you will learn from Curia’s VP of Portfolio and Sourcing, James Grabowski, about Curia’s small and large molecules most recent technologies, and capabilities.
Related Content
Trending on PharmExec
1
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
2
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
5